These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 6138469

  • 1. The effects of beta-adrenoceptor blocking drugs on non-esterified fatty acid release from adipocytes.
    Harms HH.
    J Pharmacol; 1983; 14 Suppl 2():209-15. PubMed ID: 6138469
    [Abstract] [Full Text] [Related]

  • 2. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
    Traunecker W.
    Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032
    [Abstract] [Full Text] [Related]

  • 3. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC, Parkes MW.
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [Abstract] [Full Text] [Related]

  • 4. Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.
    Naselsky DP, Ashton D, Ruffolo RR, Hieble JP.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):219-25. PubMed ID: 11408545
    [Abstract] [Full Text] [Related]

  • 5. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
    Carpéné C, Galitzky J, Collon P, Esclapez F, Dauzats M, Lafontan M.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
    [Abstract] [Full Text] [Related]

  • 6. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells.
    Hamilton BS, Doods HN.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):55-62. PubMed ID: 18031735
    [Abstract] [Full Text] [Related]

  • 7. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P, Sarsero D, Arch JR, Kelly J, Henson SM, Kaumann AJ.
    Br J Pharmacol; 1997 Jan 02; 120(2):165-76. PubMed ID: 9117106
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle.
    Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, Ajisawa Y.
    Br J Pharmacol; 1998 Jun 02; 124(3):593-9. PubMed ID: 9647486
    [Abstract] [Full Text] [Related]

  • 10. Net release of individual fatty acids from white adipose tissue during lipolysis in vitro: evidence for selective fatty acid re-uptake.
    Raclot T, Oudart H.
    Biochem J; 2000 May 15; 348 Pt 1(Pt 1):129-36. PubMed ID: 10794723
    [Abstract] [Full Text] [Related]

  • 11. Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents.
    Hellenbrecht D, Gortner L.
    Pol J Pharmacol Pharm; 1976 May 15; 28(6):625-30. PubMed ID: 13353
    [Abstract] [Full Text] [Related]

  • 12. Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
    Bhatt LK, Nandakumar K, Bodhankar SL, Bansal J, Piplani P.
    J Pharm Pharmacol; 2007 Mar 15; 59(3):429-36. PubMed ID: 17331347
    [Abstract] [Full Text] [Related]

  • 13. Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.
    Harms HH, Van der Meer J.
    Br J Clin Pharmacol; 1975 Aug 15; 2(4):311-5. PubMed ID: 9950
    [Abstract] [Full Text] [Related]

  • 14. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
    Nisoli E, Tonello C, Landi M, Carruba MO.
    Mol Pharmacol; 1996 Jan 15; 49(1):7-14. PubMed ID: 8569714
    [Abstract] [Full Text] [Related]

  • 15. Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung.
    Engel G.
    Postgrad Med J; 1981 Jan 15; 57 Suppl 1():77-83. PubMed ID: 6272254
    [Abstract] [Full Text] [Related]

  • 16. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 15; 34(10):1020-8. PubMed ID: 17714089
    [Abstract] [Full Text] [Related]

  • 17. [The use of neurotropic drugs in the study of the mechanisms of nonesterified fatty acid mobilization evoked by overstimulation in rats].
    Nikul'cheva NG.
    Farmakol Toksikol; 1972 Oct 15; 35(5):610-5. PubMed ID: 4405635
    [No Abstract] [Full Text] [Related]

  • 18. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro.
    Wenkeová J, Kuhn E, Wenke M.
    Eur J Pharmacol; 1976 May 15; 37(1):91-5. PubMed ID: 6293
    [Abstract] [Full Text] [Related]

  • 19. Comparative studies on the physiology of adipose tissue.
    Rudman D, DiGirolamo M.
    Adv Lipid Res; 1967 May 15; 5():35-117. PubMed ID: 4866077
    [No Abstract] [Full Text] [Related]

  • 20. Beta-adrenoceptor blocking agents and lipolysis.
    Harms HH, De Vente J, Zaagsma J.
    Br J Clin Pharmacol; 1982 May 15; 13(Suppl 2):181S-186S. PubMed ID: 6125168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.